DE60128407D1 - Verwendung einer pharmazeutischen zusammensetzung enthaltend zwei quaternäre ammoniumverbindungen und eine organometal-verbindung zur behandlung von viralen und fungalen infekten und krankheiten - Google Patents

Verwendung einer pharmazeutischen zusammensetzung enthaltend zwei quaternäre ammoniumverbindungen und eine organometal-verbindung zur behandlung von viralen und fungalen infekten und krankheiten

Info

Publication number
DE60128407D1
DE60128407D1 DE60128407T DE60128407T DE60128407D1 DE 60128407 D1 DE60128407 D1 DE 60128407D1 DE 60128407 T DE60128407 T DE 60128407T DE 60128407 T DE60128407 T DE 60128407T DE 60128407 D1 DE60128407 D1 DE 60128407D1
Authority
DE
Germany
Prior art keywords
viral
diseases
pharmaceutical composition
fungal infections
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60128407T
Other languages
English (en)
Other versions
DE60128407T2 (de
Inventor
Mark W Phillips
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zetetic Research Inc
Original Assignee
Zetetic Research Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zetetic Research Inc filed Critical Zetetic Research Inc
Application granted granted Critical
Publication of DE60128407D1 publication Critical patent/DE60128407D1/de
Publication of DE60128407T2 publication Critical patent/DE60128407T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/32—Tin compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/315—Zinc compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
DE60128407T 2000-01-10 2001-01-09 Verwendung einer pharmazeutischen zusammensetzung enthaltend zwei quaternäre ammoniumverbindungen und eine organometal-verbindung zur behandlung von viralen und fungalen infekten und krankheiten Expired - Lifetime DE60128407T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US17531300P 2000-01-10 2000-01-10
US175313P 2000-01-10
PCT/US2001/000605 WO2001051603A2 (en) 2000-01-10 2001-01-09 Pharmaceutical composition and method of using the same

Publications (2)

Publication Number Publication Date
DE60128407D1 true DE60128407D1 (de) 2007-06-21
DE60128407T2 DE60128407T2 (de) 2008-01-10

Family

ID=22639801

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60128407T Expired - Lifetime DE60128407T2 (de) 2000-01-10 2001-01-09 Verwendung einer pharmazeutischen zusammensetzung enthaltend zwei quaternäre ammoniumverbindungen und eine organometal-verbindung zur behandlung von viralen und fungalen infekten und krankheiten

Country Status (7)

Country Link
US (2) US6420421B1 (de)
EP (1) EP1408941B1 (de)
AT (1) ATE361744T1 (de)
AU (1) AU2001226361A1 (de)
CA (1) CA2396368A1 (de)
DE (1) DE60128407T2 (de)
WO (1) WO2001051603A2 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2371625C (en) * 1999-04-30 2012-04-17 Slil Biomedical Corporation Polyamines and their use in therapy
JP2002543163A (ja) * 1999-04-30 2002-12-17 スリル バイオメディカル コーポレイション 癌および前立腺疾患のための治療としての結合体
AU2001297817A1 (en) * 2000-11-08 2002-11-25 Eli Lilly And Company Antiviral therapies using polyamine or polyamine analog-amino acid conjugates
JP2005506354A (ja) * 2001-10-16 2005-03-03 スリル バイオメディカル コーポレイション 癌治療のためのオリゴアミン化合物およびその誘導体
FR2890565A1 (fr) * 2005-09-12 2007-03-16 Laurent Roger Thierry Clerc Procedes et composition d'une formulation inedite pour le traitement de maladies infectieuses chez l'homme ou l'animal
US20110045103A1 (en) * 2009-08-19 2011-02-24 Abukurah Abdul R Methods for treating aids
AU2019223085A1 (en) * 2018-02-23 2020-09-24 The Administrators Of The Tulane Educational Fund Pharmaceutical composition for viral infections

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3594468A (en) 1969-04-01 1971-07-20 Vincent R Saurino Germicidal compositions
US4021537A (en) * 1973-08-09 1977-05-03 Research Lab Products, Inc. Oral bactericidal compositions
US4343815A (en) 1973-08-30 1982-08-10 M&T Chemicals Inc. Method for combating fungi and mites using certain triorganotin compounds
GB1476862A (en) * 1974-11-13 1977-06-16 Rossmore H Antimicrobial compositions and methods
US4204954A (en) 1978-08-01 1980-05-27 Chemed Corporation Detoxification of residual quaternaries
US4321277A (en) 1978-12-04 1982-03-23 Research Lab Products, Inc. Germicidal use of compositions containing certain quaternary ammonium compounds
US4263278A (en) 1979-07-10 1981-04-21 Saurino Vincent R Mortuary composition
US4283421A (en) * 1979-12-19 1981-08-11 Ray Frank F Anti-viral treatment
US4464398A (en) 1981-08-11 1984-08-07 Huntington Laboratories, Inc. Germicide and an improved method for killing bacteria, fungus and/or viruses
US4902720A (en) 1983-01-10 1990-02-20 Baldone Joseph A Treatment of virus infections with quaternary ammonium compounds
US4797420A (en) 1984-08-14 1989-01-10 Jabco Manufacturing, Inc. Disinfectant formulation and method of use
DE3516695A1 (de) 1985-05-09 1986-11-13 Schering AG, 1000 Berlin und 4709 Bergkamen Biozide tributylzinnverbindungen
DK156159C (da) 1986-04-10 1989-11-27 Gori As Fremgangsmaade til stabilisering af tributyltin-fungicider til traebeskyttelse
US4732911A (en) 1987-03-13 1988-03-22 Betz Laboratories, Inc. Biocidal compositions and use thereof containing a synergistic mixture of 2-bromo-2-nitropropane-1,3-diol and bis (tri n-butyl tin) oxide
US4928629A (en) 1988-06-13 1990-05-29 Iowa State University Research Foundation, Inc. Egg inoculation method
US4914132A (en) 1989-05-25 1990-04-03 Betz Laboratories, Inc. Biocidal compositions and use thereof containing a synergistic mixute of 2-(decylthio)ethanamine hydrochloride and n-alkyl dimethyl benzyl ammonium chloride
US4998984A (en) 1989-11-15 1991-03-12 Mcclendon Evelyn Premoistened prepackaged disposable disinfectant wiper
WO1993018745A1 (en) * 1992-03-23 1993-09-30 Geda International S.A. Use of antiviral coating for latex items such as condoms
US5169536A (en) 1992-04-28 1992-12-08 Betz Laboratories, Inc. Detoxification agents for surfactant based biocides
US5336305A (en) 1993-07-06 1994-08-09 International Laboratory Technology Corp. Flexible material having barrier properties
US5417968A (en) 1993-08-16 1995-05-23 International Laboratory Technology Corp. Antimicrobial barrier composition
US5444094A (en) 1993-08-24 1995-08-22 Stepan Company Methods and compositions for disinfecting surfaces containing tuberculosis causing bacteria
US5611938A (en) 1995-02-28 1997-03-18 Ashland Inc. Biocidal blends of quaternary ammonium compounds and chlorine dioxide
US5698207A (en) 1995-07-26 1997-12-16 International Laboratory Technology Corp. Burn treatment composition

Also Published As

Publication number Publication date
US6420421B1 (en) 2002-07-16
CA2396368A1 (en) 2001-07-19
EP1408941A2 (de) 2004-04-21
AU2001226361A1 (en) 2001-07-24
EP1408941A4 (de) 2006-01-25
DE60128407T2 (de) 2008-01-10
WO2001051603A2 (en) 2001-07-19
ATE361744T1 (de) 2007-06-15
WO2001051603A3 (en) 2001-12-13
US20020061926A1 (en) 2002-05-23
EP1408941B1 (de) 2007-05-09
US6462079B2 (en) 2002-10-08

Similar Documents

Publication Publication Date Title
DE60031396D1 (de) Zubereitung zur behandlung von einer neurologischen erkrankung
ATE185066T1 (de) Lösung zur verwendung gegen den pilzbefall von nägeln
ATE487493T1 (de) Azolsäure-derivate, allein oder kombiniert, zur behandlung von diabetes und dyslipidaemien; und zur behandlung von malignen erkrankungen
DE69925256D1 (de) Trisubstituierte 1,3,5-triazine derivate zur behandlung von hiv infektionen
ATE309794T1 (de) Methode zur hemmung des wachstums von bakterien oder pilzen mit einem komplexbildner
ATE264846T1 (de) Substituierte benzimidazol-derivaten und ihre verwendung zur behandlung retroviraler infektionen
DE69821667D1 (de) Kardioverter zur Behandlung von Vorhofflattern
DE60233265D1 (de) 5-sulfanyl-4h-1,2,4-triazolderivate und deren verwendung zur behandlung von somatostatine vermittelten krankheiten
DE69422450D1 (de) Chinoline oder Chinazolin-Derivate und deren Verwendung zur Herstellung eines Medikaments für die Behandlung von Osteoporose
ATE163645T1 (de) Eintopfverfahren zur herstellung von 3- chinoloncarbonsäurederivaten
ATE336997T1 (de) Fulvinsäure und dessen verwendung zur behandlung von diversen krankheitszuständen
DE60136826D1 (de) Verwendung von asiatsäure oder asiaticosid zur behandlung von krebs
FI935777A (fi) AIDSin hoitamisessa käyttökelpoiset HIV-proteaasin inhibiittorit
EE200300504A (et) 3,7-diasabitsüklo[3.3.1]preparaadid, nende valmistamise meetod ja nimetatud preparaatide kasutaminesüdame arütmiate profülaktikas või ravis
DE60128407D1 (de) Verwendung einer pharmazeutischen zusammensetzung enthaltend zwei quaternäre ammoniumverbindungen und eine organometal-verbindung zur behandlung von viralen und fungalen infekten und krankheiten
EA200000242A1 (ru) Применение фанхинона для лечения болезни альцгеймера
TR200101841T2 (tr) Enfeksiyonlardan korunmak ve enfeksiyon tedavisi için bifosfonatların kullanılmaları
ATE148109T1 (de) Hiv-proteaseinhibitoren und ihre verwendung zur behandlung von aids
ATE294584T1 (de) Verwendung von desoxypeganin zur behandlung von alzheimerischer demenz
ATE344662T1 (de) Mittel enthaltend n-chlortaurin sowie dessen verwendung zur behandlung von schleimhautpolypen
EE200300495A (et) 3,7-diasabitsüklo[3.3.1]preparaadid, nende valmistamise meetod ja nimetatud preparaatide kasutaminesüdame arütmiate profülaktikas või ravis
EE200300506A (et) 3,7-diasabitsüklo[3.3.1]preparaadid, nende valmistamise meetod ja nimetatud preparaatide kasutaminesüdame arütmiate profülaktikas või ravis
DE69906701D1 (de) Topische verwendung von loperamid zur behandlung mikrobieller infektionen
ATE145828T1 (de) Verfahren zur desinfektion von muskelskelettgeweben und so aufbereitete gewebe
ATE306275T1 (de) Pharmazeutische zubereitungen zur behandlung von dns viraler infektionen, welche ein schleifendiureticum und lithium enthalten

Legal Events

Date Code Title Description
8364 No opposition during term of opposition